In this article, we will list the 5 Most Promising Mid-Cap Stocks to Buy According to Analysts. Please visit 10 Most Promising Mid-Cap Stocks to Buy According to Analysts to see the extended list and the methodology behind it.
5. Viasat Inc. (NASDAQ:VSAT)
Average Upside Potential: 51.70%
Viasat Inc. (NASDAQ:VSAT) is one of the most promising mid-cap stocks to buy according to analysts. On May 28, Viasat reported record financial performance for its Q4 and full-year 2026, including $4.9 billion in awards and a $4.1 billion backlog, alongside record revenue of $4.6 billion and adjusted EBITDA of $1.6 billion. Free cash flow improved year over year to $177 million, marking the fifth consecutive quarter of positive free cash flow generation, while net losses narrowed significantly compared to the prior year.
Operationally, the business advanced major satellite and communications programs, including successful launches of ViaSat-3 spacecraft and continued expansion of global coverage across mobility, government, and maritime markets. The company also grew its cybersecurity and government communications portfolios, securing record contract awards across encryption, defense, and satellite communications programs.
Financially, Viasat Inc. (NASDAQ:VSAT) strengthened its balance sheet by reducing debt through early redemption of senior notes and repayment of term loans, while maintaining $2.9 billion in liquidity. Strategic initiatives also included expansion of multi-orbit connectivity solutions, growth in aviation and shipping connectivity services, and the divestiture of a JV interest at an accretive valuation.
Viasat Inc. (NASDAQ:VSAT) is a global broadband and communication service provider that delivers satellite-based broadband services, narrowband communications, secure networking systems, and cybersecurity solutions. The company has two segments: Communication Services and Defense & Advanced Technologies. It also develops wireless products, terminals, and space system solutions.
4. Cytokinetics (NASDAQ:CYTK)
Average Upside Potential: 51.94%
Cytokinetics (NASDAQ:CYTK) is one of the most promising mid-cap stocks to buy according to analysts. On June 1, Cytokinetics announced the first commercial European launch of MYQORZO (aficamten) in Germany for the treatment of symptomatic obstructive hypertrophic cardiomyopathy/oHCM. The launch follows European Commission approval in February and builds on prior regulatory approvals in the US and China.
MYQORZO is a cardiac myosin inhibitor designed to reduce cardiac contractility and left ventricular outflow tract obstruction in patients with oHCM. Its approval was supported by Phase 3 SEQUOIA-HCM clinical trial results, which showed statistically significant improvements across exercise capacity, symptoms, hemodynamics, and quality-of-life measures compared to placebo.
Cytokinetics (NASDAQ:CYTK) stated that the German launch marks the first step in a broader European rollout strategy aimed at expanding access to the therapy across the region. The company emphasized strong clinical outcomes and regulatory validation as key drivers supporting its global commercialization of aficamten in treating hypertrophic cardiomyopathy.
Cytokinetics (NASDAQ:CYTK) is a biopharmaceutical company that discovers, develops, and commercializes muscle activators and muscle inhibitors as potential treatments for debilitating diseases. The company’s clinical-stage drug candidates include omecamtiv mecarbil, CK-136, reldesemtiv, aficamten, and CK-3772271.
3. AeroVironment Inc. (NASDAQ:AVAV)
Average Upside Potential: 68.55%
AeroVironment Inc. (NASDAQ:AVAV) is one of the most promising mid-cap stocks to buy according to analysts. On June 2, AeroVironment announced plans to invest $15 million to expand its advanced production capabilities in Greene County near Dayton, Ohio. The expansion includes new facilities in Beavercreek and Xenia to support pilot-scale and mid-volume production, including advanced biotechnology manufacturing and defense-related components.
The project is designed to strengthen domestic manufacturing capacity for critical defense and biotechnology programs, with close proximity to the Air Force Research Laboratory /AFRL and Wright-Patterson Air Force Base. The expanded sites will support manufacturing, integration, and testing activities aligned with national security priorities, while also enabling future scale-up into full-rate production.
The investment is expected to create around 200 new jobs and generate significant regional economic impact, supported by state and regional incentive programs. AeroVironment Inc. (NASDAQ:AVAV) emphasized that the expansion is part of a broader strategy to enhance US defense manufacturing capacity, improve supply chain resilience, and accelerate the development of advanced mission-critical technologies.
AeroVironment Inc. (NASDAQ:AVAV) designs and manufactures unmanned aerial vehicles, ground robotic systems, and loitering munitions.
2. Chewy Inc. (NYSE:CHWY)
Average Upside Potential: 96.08%
Chewy Inc. (NYSE:CHWY) is one of the most promising mid-cap stocks to buy according to analysts. On June 10, Chewy reported its FQ1 2026 financial results, highlighting continued growth in revenue and profitability. The company posted net sales of $3.36 billion, representing a 7.7% year-over-year increase, alongside improved gross margin and net income performance.
Profitability metrics strengthened during the quarter, with net income reaching $94.8 million and adjusted EBITDA rising to $253.1 million. Margins also expanded across multiple measures, reflecting improved operational efficiency and continued scaling of the company’s digital retail platform.
Management attributed the results to strong customer growth, market share gains in the pet category, and disciplined execution across its business model. The company emphasized its ongoing focus on profitable expansion, customer acquisition, and long-term shareholder value creation in a competitive consumer environment.
Chewy Inc. (NYSE:CHWY) is involved in the e-commerce business across the United States. The company provides pet supplies and medications, pet food and treats, and other pet health products. It is based in Plantation, Florida, and was incorporated in 2010.
1. BitMine Immersion Technologies Inc. (NYSE:BMNR)
Average Upside Potential: 140.74%
BitMine Immersion Technologies Inc. (NYSE:BMNR) is one of the most promising mid-cap stocks to buy according to analysts. On June 8, BitMine Immersion reported that its total crypto and cash holdings reached $9.6 billion, driven primarily by a large Ethereum/ETH treasury position. The company disclosed holdings of over 5.5 million ETH, alongside smaller Bitcoin positions, cash reserves, and additional strategic investments.
The company stated it now controls approximately 4.59% of the total ETH supply, supported by aggressive accumulation and large-scale staking operations. A significant portion of its ETH holdings is staked through its institutional staking platform, MAVAN, contributing to projected annual staking revenue and reinforcing BitMine’s position as one of the largest Ethereum treasuries globally.
BitMine Immersion Technologies Inc. (NYSE:BMNR) also highlighted broader strategic investments and infrastructure expansion in the crypto ecosystem, including staking platform development and equity “moonshot” positions. Management emphasized Ethereum’s long-term role in supporting decentralized finance and AI-driven systems, framing the company’s accumulation strategy as aligned with expected growth in blockchain adoption and network utility.
BitMine Immersion Technologies Inc. (NYSE:BMNR) is a digital asset company. It was originally focused on Bitcoin mining and hosting services, but has pivoted toward building a massive Ethereum treasury. The company has also developed infrastructure such as its MAVAN validator network, which serves as an institutional-grade Ethereum staking platform.
While we acknowledge the potential of BMNR to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than BMNR and that has 100x upside potential, check out our report about the cheapest AI stock.
READ NEXT: 10 Most Undervalued Large Cap Stocks to Buy According to Analysts and 10 Most Promising Penny Stocks According to Wall Street Analysts.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
